CMLF Stock Price, News & Analysis

CMLF NASDAQ

Company Description

CMLF (NASDAQ: CMLF) is a publicly traded company.

CMLF stock has gained 18.4% over the past year.

This page provides a comprehensive overview of CMLF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+18.37%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

CMLF (CMLF) stock. Over the past 12 months, the stock has gained 18.4%.

Latest News

View All

July 7, 2021

-3.76%

Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors

management

July 2, 2021

-2.07%

CM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business Combination

June 17, 2021

+8.63%

Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer

management

June 10, 2021

+2.85%

Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement

May 25, 2021

+3.00%

AdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and Outcomes

May 24, 2021

+1.52%

Sema4 to Participate in Upcoming Investor Conferences

conferences

CMLF has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include management, conferences, acquisition, clinical trial, AI. View all CMLF news →

SEC Filings

View All

No SEC filings available for CMLF.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months